Hormone replacement therapy-induced pain and redness of the feet.
Clin Exp Dermatol
; 47(12): 2290-2292, 2022 Dec.
Article
in En
| MEDLINE
| ID: mdl-35941758
ABSTRACT
We report the first case, to our knowledge, of a patient who developed erythromelalgia after receiving oestrogen-progestin replacement therapy (Femoston). The patient had complete remission after taking glycyrrhizin and pregabalin for 3 months. This case expands the spectrum of erythromelalgia and provides a therapeutic option.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Erythromelalgia
Limits:
Humans
Language:
En
Journal:
Clin Exp Dermatol
Year:
2022
Type:
Article
Affiliation country:
China